540694 Stock Overview Manufactures and sells pharmaceuticals products and formulations in India. More details
Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
ANG Lifesciences India Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for ANG Lifesciences India Historical stock prices Current Share Price ₹44.75 52 Week High ₹83.50 52 Week Low ₹42.02 Beta 0.52 1 Month Change -6.73% 3 Month Change -11.18% 1 Year Change -41.97% 3 Year Change -88.20% 5 Year Change 213.81% Change since IPO 16.54%
Recent News & Updates
Ang Lifesciences India Limited Announces Resignation of Renu Kaur as Company Secretary, Effective December 16, 2024 Dec 19
ANG Lifesciences India Limited to Report Q2, 2025 Results on Nov 14, 2024 Nov 09
ANG Lifesciences India Limited, Annual General Meeting, Sep 30, 2024 Sep 12
First quarter 2025 earnings released: ₹2.35 loss per share (vs ₹1.41 profit in 1Q 2024) Aug 16
ANG Lifesciences India Limited to Report Q1, 2025 Results on Aug 14, 2024 Aug 08
Full year 2024 earnings released: ₹7.61 loss per share (vs ₹0.20 loss in FY 2023) Jun 04 See more updates
Ang Lifesciences India Limited Announces Resignation of Renu Kaur as Company Secretary, Effective December 16, 2024 Dec 19
ANG Lifesciences India Limited to Report Q2, 2025 Results on Nov 14, 2024 Nov 09
ANG Lifesciences India Limited, Annual General Meeting, Sep 30, 2024 Sep 12
First quarter 2025 earnings released: ₹2.35 loss per share (vs ₹1.41 profit in 1Q 2024) Aug 16
ANG Lifesciences India Limited to Report Q1, 2025 Results on Aug 14, 2024 Aug 08
Full year 2024 earnings released: ₹7.61 loss per share (vs ₹0.20 loss in FY 2023) Jun 04
New major risk - Revenue and earnings growth Feb 17
Third quarter 2024 earnings released: ₹4.52 loss per share (vs ₹1.36 loss in 3Q 2023) Feb 17
ANG Lifesciences India Limited to Report Q3, 2024 Results on Feb 14, 2024 Feb 08
New major risk - Market cap size Nov 24
New major risk - Financial position Nov 22
Second quarter 2024 earnings released Nov 20
ANG Lifesciences India Limited Announces Resignation of Neeraj Gupta as Chief Financial Officer Oct 16 ANG Lifesciences India Limited Appoints Rohit Mittal as Additional Director (Non-Executive Non Independent Director)
ANG Lifesciences India Limited, Annual General Meeting, Sep 30, 2023 Sep 06
First quarter 2024 earnings released: EPS: ₹1.41 (vs ₹3.19 in 1Q 2023) Aug 16 ANG Lifesciences India Limited to Report Q1, 2024 Results on Aug 14, 2023 Aug 06
New major risk - Market cap size Aug 02
Full year 2023 earnings released: EPS: ₹0.36 (vs ₹31.11 in FY 2022) Jun 03
ANG Lifesciences India Limited to Report Q4, 2023 Results on May 30, 2023 May 25
Investor sentiment improves as stock rises 15% Apr 11
Investor sentiment deteriorates as stock falls 20% Mar 17
Investor sentiment improves as stock rises 18% Mar 03
Investor sentiment deteriorates as stock falls 25% Feb 15
Third quarter 2023 earnings released: ₹1.36 loss per share (vs ₹1.03 profit in 3Q 2022) Feb 15
ANG Lifesciences India Limited to Report Q3, 2023 Results on Feb 14, 2023 Feb 07
ANG Lifesciences India Limited Announces Resignation of Subodh Sharma as Chief Financial Officer Dec 06
ANG Lifesciences India Limited announced that it expects to receive INR 20 million in funding Dec 01
Investor sentiment deteriorated over the past week Nov 21
Second quarter 2023 earnings released Nov 20
ANG Lifesciences India Limited to Report Q2, 2023 Results on Nov 14, 2022 Nov 06
Investor sentiment improved over the past week Sep 09
ANG Lifesciences India Limited, Annual General Meeting, Sep 30, 2022 Sep 07
ANG Lifesciences India Limited, Annual General Meeting, Sep 30, 2022 Sep 06
First quarter 2023 earnings released: EPS: ₹3.99 (vs ₹13.03 in 1Q 2022) Aug 18
ANG Lifesciences India Limited to Report Q1, 2023 Results on Aug 14, 2022 Aug 07
Investor sentiment improved over the past week Jul 07
Investor sentiment deteriorated over the past week Jun 20
Full year 2022 earnings released: EPS: ₹39.09 (vs ₹6.78 in FY 2021) Jun 02
Investor sentiment improved over the past week May 26
ANG Lifesciences India Limited to Report Q4, 2022 Results on May 30, 2022 May 22
Investor sentiment deteriorated over the past week May 10
Investor sentiment improved over the past week Apr 07
ANG Lifesciences India Limited Approves Re-Constitution of Committee Mar 31
Investor sentiment improved over the past week Feb 28
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 16
Investor sentiment deteriorated over the past week Feb 14
Investor sentiment improved over the past week Dec 07
ANG Lifesciences India Limited (BSE:540694) agreed to acquire ANG Healthcare India Private Limited for INR 40 million. Nov 25
Investor sentiment deteriorated over the past week Nov 17
First half 2022 earnings released: EPS ₹32.58 (vs ₹5.31 in 1H 2021) Oct 29
Investor sentiment improved over the past week Oct 26
Investor sentiment improved over the past week Oct 06
Investor sentiment deteriorated over the past week Sep 22
Investor sentiment improved over the past week Sep 02
ANG Lifesciences India Limited (BSE:540694) acquired Two Formulation Manufacturing Facilities from Ind-Swift Limited (BSE:524652) for INR 600 million. Aug 15
Company Secretary & Compliance Officer Preeti Goel has left the company Aug 12
Full year 2021 earnings released: EPS ₹13.56 (vs ₹11.76 in FY 2020) Jul 06
Investor sentiment deteriorated over the past week Jul 02
Investor sentiment improved over the past week May 18
Investor sentiment improved over the past week May 01
Investor sentiment improved over the past week Apr 16
Investor sentiment improved over the past week Mar 05
New 90-day high: ₹84.00 Mar 04
ANG Lifesciences India Limited, Annual General Meeting, Dec 30, 2020 Dec 10
Market bids up stock over the past week Nov 13
New 90-day high: ₹61.20 Nov 13
ANG Lifesciences India Limited to Report First Half, 2021 Results on Nov 12, 2020 Nov 07
New 90-day high - ₹45.95 Aug 17 Shareholder Returns 540694 IN Pharmaceuticals IN Market 7D -0.4% 3.1% 0.5% 1Y -42.0% 36.2% 17.4%
See full shareholder returns
Return vs Market: 540694 underperformed the Indian Market which returned 17.4% over the past year.
Price Volatility Is 540694's price volatile compared to industry and market? 540694 volatility 540694 Average Weekly Movement 4.3% Pharmaceuticals Industry Average Movement 5.9% Market Average Movement 6.2% 10% most volatile stocks in IN Market 9.0% 10% least volatile stocks in IN Market 4.1%
Stable Share Price: 540694 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 540694's weekly volatility (4%) has been stable over the past year.
About the Company ANG Lifesciences India Limited manufactures and sells pharmaceuticals products and formulations in India. The company’s products include various therapeutic categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. It offers finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, prefilled syringes, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, and lotions.
Show more ANG Lifesciences India Limited Fundamentals Summary How do ANG Lifesciences India's earnings and revenue compare to its market cap? 540694 fundamental statistics Market cap ₹584.36m Earnings (TTM ) -₹147.40m Revenue (TTM ) ₹1.08b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 540694 income statement (TTM ) Revenue ₹1.08b Cost of Revenue ₹697.60m Gross Profit ₹379.20m Other Expenses ₹526.60m Earnings -₹147.40m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -11.29 Gross Margin 35.22% Net Profit Margin -13.69% Debt/Equity Ratio 115.6%
How did 540694 perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/02 01:38 End of Day Share Price 2025/01/02 00:00 Earnings 2024/09/30 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources ANG Lifesciences India Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
